VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
LNAILunai Bioworks Inc.
$4.37$20M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksLNAIEarnings History

LNAI logoLunai Bioworks Inc. (LNAI) Earnings History

Net Loss

5 years of earnings data (2020–2024) · Currently unprofitable on a TTM basis

TTM Net Income
-$128M
● Net Loss
TTM EPS (Diluted)
$-41.06
Per share, diluted
YoY EPS Growth
-18.5%
Declining
Net Margin
N/A
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating MarginN/A
Gross MarginN/A
Return on Equity-321.8%
Return on Assets-207.8%
Record Annual Net Income-$27MFY2020
Record Quarterly EPS$1.04Q1 2025
Consecutive Profitable Years0years
Q3 2025
Net Income-$3M
EPS (Diluted)$-0.80
YoY Growth-18.5%Declining
QoQ Growth-42.9%Declining

Loading earnings history...

Lunai Bioworks Inc. (LNAI) Earnings Overview

As of June 24, 2026, Lunai Bioworks Inc. (LNAI) reported trailing twelve-month net income of -$128M, reflecting -18.5% year-over-year growth. The company earned $-41.06 per diluted share over the past four quarters.

Looking at the long-term picture, LNAI's historical earnings data spans multiple years. The company achieved its highest annual net income of -$27M in fiscal 2020.

Lunai Bioworks Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including BEAM (-$65M net income, -57.2% margin), TWST (-$81M net income, -20.6% margin), CDNA (-$8M net income, -5.6% margin), LNAI has comparable earnings metrics. Compare LNAI vs BEAM →

LNAI Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
LNAI logoLNAICurrent
-$128M$-41.06--321.8%-18.5%—
BEAM logoBEAM
-$65M$-0.63-57.2%-8.1%+82.3%
TWST logoTWST
-$81M$-1.32-20.6%-16.4%+63.9%
CDNA logoCDNA
-$8M$-0.15-5.6%-6.3%-143.0%
SRPT logoSRPT
$65M$0.53-32.5%-53.5%-404.7%
NTLA logoNTLA
-$395M$-3.33-609.9%-53.5%+27.4%
Best in group
Lowest in group

LNAI Historical Earnings Data (2020–2024)

5 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2024-$178M-101.3%-$19M$-86.24--
2023-$88M-122.8%-$82M$-72.80--
2022-$40M+65.0%-$39M$-56.80--
2021-$113M-324.5%-$116M$-172.80--
2020-$27M--$23M$-45.36--

Download Data

Export LNAI earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

6+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

LNAI — Frequently Asked Questions

Quick answers to the most common questions about buying LNAI stock.

What is LNAI earnings per share (EPS)?

LNAI trailing twelve-month (TTM) diluted EPS is $-41.06, reflecting -18.5% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2020 to 2024 is available in the table on this page.

What is Lunai Bioworks Inc.'s net income?

Lunai Bioworks Inc. (LNAI) trailing twelve-month net income is $-128M as of 2024. Earnings declined -18.5% year-over-year.

Is LNAI profitable?

LNAI is not currently profitable on a TTM basis, reporting a net loss of $-128M. Net margin is N/A. Investors should monitor for a return to profitability.

What is LNAI's earnings growth rate?

LNAI compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2020 to 2024.

What are LNAI's profit margins?

Lunai Bioworks Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -321.8%.

Is LNAI growing earnings?

LNAI earnings are declining — EPS fell -18.5% year-over-year. TTM net income dropped to $-128M. This contrasts with the 5-year CAGR of N/A.

What was LNAI's best earnings year?

Lunai Bioworks Inc.'s highest annual net income on record is $-27M, achieved in fiscal year 2020. Earnings history on this page spans 2020 to 2024 and includes all annual and quarterly figures.

What were LNAI's earnings last quarter?

LNAI's most recent reported quarter was Q3 2025. Net income was $-3M with diluted EPS of $-0.80. For a full breakdown of all quarters, see the quarterly earnings table on this page.

LNAI Earnings Over Time (2020–2024)

Net income & EPS — annual and quarterly view